Entering text into the input field will update the search result below

Statera Bio pops 8% after FDA lifts clinical hold on Entolimod

Dec. 01, 2021 8:13 AM ETStatera Biopharma, Inc. (STAB)By: SA News Team

Economy Growth - Dollar Moving Up

sefa ozel/iStock via Getty Images

  • Statera Biopharma (NASDAQ:STAB) perks up 7.8% premarket following an announcement that the FDA has lifted the clinical hold placed on its Entolimod research and development activity in acute radiation syndrome (ARS).
  • Based on the Company’s response, the FDA acknowledged

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.